Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 11Terminated 6Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 36Other hematologic neoplasm 35Myeloid 18Plasma cell 9Dermatologic 6Sarcoma 5Classical hematology 4Other neoplasm 3Head & Neck 2Genitourinary 2Gastrointestinal 2CNS 2Tumor-Agnostic 1Thoracic 1Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1

Conditions

Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 45Paclitaxel 45Carboplatin 39Magnetic Resonance Spectroscopy 28olaparib 27Specimen Handling 26Cisplatin 24Bevacizumab 20Nivolumab 18Taxes 17Biopsy 16Gemcitabine 13Cyclophosphamide 13durvalumab 12Immunoglobulin G 11Doxorubicin 11Disulfides 11Surveys and Questionnaires 10niraparib 9liposomal doxorubicin 9dostarlimab 9Radiotherapy 8Brachytherapy 8lenvatinib 7fludarabine 7atezolizumab 7Letrozole 7Docetaxel 7cediranib 6Platinum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × fludarabine phosphate × Gynecologic × Clear all
NCT04670068 2025-12-22

Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
4 enrolled 8 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡